Paper42433780
The role of non-coding variants in hereditary cancer syndromes: mechanistic insights and clinical implications.
Bosco S and 9 others. Ann Med Surg (Lond), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The role of non-coding variants in hereditary cancer syndromes: mechanistic insights and clinical implications. Papers, record 42433780. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42433780
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The role of non-coding variants in hereditary cancer syndromes: mechanistic insights and clinical implications.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References59
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27662091 | Editing DNA Methylation in the Mammalian Genome. | Cell | 2016 | https://conductscience.org/library/papers/27662091 | PubMed |
| 2 | 35118379 | Cell-type-specific epigenomic variations associated with BRCA1 mutation in pre-cancer human breast tissues. | NAR Genom Bioinform | 2022 | https://conductscience.org/library/papers/35118379 | PubMed |
| 3 | 23334332 | Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. | Oncogene | 2014 | https://conductscience.org/library/papers/23334332 | PubMed |
| 4 | 28947139 | LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. | Cancer Lett | 2017 | https://conductscience.org/library/papers/28947139 | PubMed |
| 5 | 40049170 | Identifying deleterious noncoding variation through gain and loss of CTCF binding activity. | Am J Hum Genet | 2025 | https://conductscience.org/library/papers/40049170 | PubMed |
| 6 | 20827584 | Regulatory regions in DNA: promoters, enhancers, silencers, and insulators. | Methods Mol Biol | 2010 | https://conductscience.org/library/papers/20827584 | PubMed |
| 7 | 35849120 | Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles. | Clin Cancer Res | 2022 | https://conductscience.org/library/papers/35849120 | PubMed |
| 8 | 30995943 | BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells. | Breast Cancer Res | 2019 | https://conductscience.org/library/papers/30995943 | PubMed |
| 9 | 35393420 | Modification of BRCA1-associated breast cancer risk by HMMR overexpression. | Nat Commun | 2022 | https://conductscience.org/library/papers/35393420 | PubMed |
| 10 | 28283057 | Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis. | Cell | 2017 | https://conductscience.org/library/papers/28283057 | PubMed |
| 11 | 26898890 | Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations. | Hum Mutat | 2016 | https://conductscience.org/library/papers/26898890 | PubMed |
| 12 | 28938092 | CTCF-Mediated Enhancer-Promoter Interaction Is a Critical Regulator of Cell-to-Cell Variation of Gene Expression. | Mol Cell | 2017 | https://conductscience.org/library/papers/28938092 | PubMed |
| 13 | 37537618 | Enhancer RNAs: mechanisms in transcriptional regulation and functions in diseases. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37537618 | PubMed |
| 14 | 34230647 | Non-coding driver mutations in human cancer. | Nat Rev Cancer | 2021 | https://conductscience.org/library/papers/34230647 | PubMed |
| 15 | 32203205 | The intronic BRCA1 c.5407-25T>A variant causing partly skipping of exon 23-a likely pathogenic variant with reduced penetrance? | Eur J Hum Genet | 2020 | https://conductscience.org/library/papers/32203205 | PubMed |
| 16 | 27144062 | Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing. | Cancer Biol Med | 2016 | https://conductscience.org/library/papers/27144062 | PubMed |
| 17 | 34821374 | FGD5‑AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt/β‑catenin signaling pathway via miR‑577. | Oncol Rep | 2022 | https://conductscience.org/library/papers/34821374 | PubMed |
| 18 | 38722139 | Unraveling noncoding DNA variants and epimutations: a paradigm shift in hereditary cancer research. | Future Oncol | 2024 | https://conductscience.org/library/papers/38722139 | PubMed |
| 19 | 31822864 | Targeted deep-intronic sequencing in a cohort of unexplained cases of suspected Lynch syndrome. | Eur J Hum Genet | 2020 | https://conductscience.org/library/papers/31822864 | PubMed |
| 20 | 38654521 | In vitro data suggest a role for PMS2 Kozak sequence mutations in Lynch syndrome risk. | HGG Adv | 2024 | https://conductscience.org/library/papers/38654521 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42433780
GET https://conductscience.org/api/papers/v1/42433780/references?page=2